Work

Phase 2 Study of Intramyocardial Injection of Autologous CD34+ Cells to Treat Subjects with Refractory Chronic Myocardial Ischemia (CMI): Factors Influencing Mobilization and Apheresis.

FWCI:
Cites:
Cited by: 3
Related to: 10